塞来昔布对人甲状腺髓样癌TT细胞中VEGF和MMP-9表达的抑制作用及其机制

J4 ›› 2012, Vol. 38 ›› Issue (3): 543-546.

塞来昔布对人甲状腺髓样癌TT细胞中VEGF和MMP-9表达的抑制作用及其机制

李新白¹|孟宪瑛²|王广义³|张强²|李群²

1.吉林大学第一医院麻醉科,吉林长春 130021；2.吉林大学第一医院甲状腺外科,吉林长春 130021；3.吉林大学第一医院肝胆胰外科|吉林长春 130021

收稿日期:2011-12-08 出版日期:2012-05-28 发布日期:2012-05-28
通讯作者: 孟宪瑛（Tel:0431-88782786，E-mail: xy6823@163.com）王广义（Tel:0431-88783331，E-mail: wgymd@sina.com） E-mail:xy6823@163.com;wgymd@sina.com
作者简介:李新白（1975－）|女|吉林省长春市人|主治医师|在读医学博士|主要从事肿瘤基础及临床研究。
基金资助:
吉林省卫生厅科研基金资助课题（2008Z017）

Inhibitory effects of celecoxib on |expressions of VEGF  |and　 MMP-9 in human medullary thyroid TT cells and their mechanisms

LI Xin-bai¹,MENG Xian-ying²,WANG Guang-yi³,ZHANG Qiang²,LI Qun²

（1. Department of Anesthesiology,First Hospital,Jilin University,Changchun 130021,China;2. Department of Thyroid Surgery,First Hospital,Jilin University,Changchun 130021,China；3. Department of Hepatopancreatobiliary Surgery,First Hospital,Jilin University,Changchun 130021,China）

Received:2011-12-08 Online:2012-05-28 Published:2012-05-28

摘要/Abstract

摘要：

目的：探讨环氧化酶2(COX-2)选择性抑制剂塞来昔布对人甲状腺髓样癌TT细胞中血管内皮生长因子(VEGF) mRNA及基质金属蛋白酶-9(MMP-9) mRNA表达的影响，探讨塞来昔布抗肿瘤的作用机制。方法：人甲状腺髓样癌TT细胞株分为不同浓度塞来昔布组和对照组，各塞来昔布组分别给予不同浓度的塞来昔布（20、40和80 μmol?L-1），对照组给予F12K培养液，作用72 h后，采用RT-PCR方法检测不同浓度塞来昔布作用于TT细胞后VEGF mRNA和MMP-9 mRNA表达的变化。结果： 20、40和80 μmol?L-1的塞来昔布对甲状腺癌TT细胞VEGF mRNA和MMP-9 mRNA的表达均有抑制作用。40和80 μmol?L-1塞来昔布组TT细胞中VEGF/GAPDH及MMP-9/GAPDH值与对照组比较差异有统计学意义（P<0.05），结论：塞来昔布浓度高于40 μmol?L-1时可明显降低VEGF mRNA和MMP-9 mRNA的分泌，可能对肿瘤生长有一定抑制作用。

关键词: 甲状腺肿瘤；塞来昔布；血管内皮生长因子；基质金属蛋白酶-9

Abstract:

Abstract:Objective To discuss the effect of cyclooxegenase-2（COX-2） selective suppressor celecoxib on the expressions of vascular endothelial growth factor(VEGF) mRNA and matrix metalloproteinases-9(MMP-9) mRNA in human medullary thyroid TT cells,and to approach the anticancer mechanism of celecoxib.Methods The TT cells of human medullary thyroid carcinoma were divided into control group and different concertrations of celecoxib groups,and the cells in celecoxib groups were treated with different concentrations of celecoxib（20,40 and 80 μmol?L-1）,the cells in control group were treated with F12K culture fluid.The expressions of VEGF mRNA and MMP-9 mRNA in each group were detected by RT-PCR 72 h after treatment. Results the RT-PCR results showed that the expressions of VEGF mRNA and MMP-9 mRNA in TT cells were decreased after treated with 20,40 and 80 μmol?L-1 celecoxib. There was significance difference of the VEGF/GAPDH and MMP-9/GAPDH of TT cells between 40,80 μmol?L-1 celecoxib groups and control group（P<0.05）.Conclusion The secretion of VEGF mRNA and MMP-9 mRNA is decreased obviously when the concentration of celecoxib is above 40 μmol?L-1,which may inhibit the growth of tumor.

Key words: thyroid neoplasms;celecoxib;vascular endothelial growth factor;matrix metalloproteinases-9

中图分类号:

R736.1

李新白|孟宪瑛|王广义|张强|李群. 塞来昔布对人甲状腺髓样癌TT细胞中VEGF和MMP-9表达的抑制作用及其机制[J]. J4, 2012, 38(3): 543-546.

LI Xin-bai,MENG Xian-ying,WANG Guang-yi,ZHANG Qiang,LI Qun. Inhibitory effects of celecoxib on |expressions of VEGF  |and　 MMP-9 in human medullary thyroid TT cells and their mechanisms[J]. J4, 2012, 38(3): 543-546.

[1]	贺梦子，赵银龙，刘晓冬，马淑梅，刘欣. 甲状腺乳头状癌组织中差异表达miRNA及其靶基因的筛选和预测[J]. 吉林大学学报(医学版), 2013, 39(1): 99-103.
[2]	孙亚东\|张景斌\|杨乐\|马彦\|姜春浩\| 邸军 . 实时荧光定量PCR法检测EG-1在甲状腺乳头状癌组织中的表达及其临床意义[J]. J4, 2012, 38(5): 981-984.